Feasibility and Efficacy of Single Photon Emission Computed Tomography-Based Three-Dimensional Conformal Radiotherapy for Hepatocellular Carcinoma 8 cm or More With Portal Vein Tumor Thrombus in Combination With Transcatheter Arterial Chemoembolization

International Journal of Radiation Oncology Biology Physics

Volumn 76, Issue 4, 2010, Pages 1037-1044

  Shirai, Shintaro ^a   Sato, Morio ^a   Suwa, Kazuhiro ^a   Kishi, Kazushi ^a   Shimono, Chigusa ^a   Sonomura, Tetsuo ^a   Kawai, Nobuyuki ^a   Tanihata, Hirohiko ^a   Minamiguchi, Hiroki ^a   Nakai, Motoki ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Functional image guided radiotherapy; Hepatocellular carcinoma; Portal vein tumor thrombus; Tc 99m galactosyl human serum albumin; Three dimensional conformal radiotherapy

Indexed keywords

FUNCTIONAL IMAGES; HEPATOCELLULAR CARCINOMA; HUMAN SERUM ALBUMINS; PORTAL VEIN TUMOR THROMBUS; THREE-DIMENSIONAL CONFORMAL RADIOTHERAPY;

BODY FLUIDS; FLUORESCENT SCREENS; IRRADIATION; LIVER; PARTICLE BEAMS; PHOTONS; RADIOTHERAPY; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY; TOMOGRAPHY; TUMORS;

THREE DIMENSIONAL;

AMINOTRANSFERASE; TECHNETIUM 99M;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL ARTICLE; FEMALE; HUMAN; HYPERBILIRUBINEMIA; HYPOALBUMINEMIA; LIVER CELL CARCINOMA; MALE; PHOTON EMISSION TOMOGRAPHY; PORTAL VEIN; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; RADIATION DOSE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THREE DIMENSIONAL IMAGING;

AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; COMBINED MODALITY THERAPY; FEASIBILITY STUDIES; FEMALE; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PORTAL VEIN; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; SURVIVAL RATE; TECHNETIUM TC 99M AGGREGATED ALBUMIN; TECHNETIUM TC 99M PENTETATE; THROMBOSIS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TUMOR BURDEN;

EID: 77449094020     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.03.023     Document Type: Article

References (16)

1. Yamada R., Sato M., Kawabata M., et al. Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 148 (1983) 397-401
2. Arata S., Tanaka K., Okazaki H., et al. Risk factors for recurrence of large HCC in patients treated by combined TAE and PEI. Hepatogastroenterology 48 (2001) 480-485
3. Group d'Etude et de Traitement de Carcinome Hepatocellulaire. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 332 (1995) 1256-1261
4. Bruix J., Llovet J.M., Castells A., et al. Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: Results of a randomized controlled trial in a single institution. Hepatology 27 (1998) 1578-1583
5. Llovet J.M., Real M.I., Montana X., et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: A randomized controlled trial. Lancet 359 (2002) 1734-1739
6. Lo C.M., Ngan H., Tso W.K., et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 35 (2002) 1164-1171
7. Sawamura T., Nakada H., Hazama H., et al. Hyperasialoglycoproteinemia in patients with chronic liver disease and/or liver cell carcinoma. Gastroenterology 87 (1984) 1217-1221
8. Nanashima A., Yamaguchi H., Shibasaki S., et al. Relationship between CT volumetry and functional liver volume using technetium-99m galactosyl serum albumin scintigraphy in patients undergoing preoperative portal vein embolization before major hepatectomy: A preliminary study. Dig Dis Sci 51 (2006) 1190-1195
9. Dawson L.A., Normolle D., Balter J.M., et al. Analysis of radiation-induced liver disease using the Lyman NTCP model. Int J Radiat Oncol Biol Phys 53 (2002) 810-821
10. Shirai S., Sato M., Suwa K., et al. Single photon emission computed tomography-based three-dimensional conformal radiotherapy for hepatocellular carcinoma with portal vein tumor thrombus. Int J Radiat Oncol Biol Phys 73 (2009) 824-831
11. Emami B., Lyman J., Brown A., et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21 (1991) 109-122
12. Park W., Lim D.H., Paik S.W., et al. Local radiotherapy for patients with unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 61 (2005) 1143-1150
13. Park H.C., Seong J., Han K.H., et al. Dose-response relationship in local radiotherapy for hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 54 (2002) 150-155
14. Kim T.H., Kim D.Y., Park J.W., et al. Dose-volumetric parameters predicting radiation-induced hepatic toxicity in unresectable hepatocellular carcinoma patients treated with three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 67 (2007) 225-231
15. Liang S.X., Zhu X.D., Xu Z.Y., et al. Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma: The risk factors and hepatic radiation tolerance. Int J Radiat Oncol Biol Phys 65 (2006) 426-434
16. Shirai S., Kishi K., Shimono T., et al. Radiation therapy (RT) for hepatocellular carcinoma (HCC) with portal tumor thrombi (PVTT) of main portal vein and/or the 1st branch (in Japanese). Jpn J Clin Radiol 51 (2006) 1189-1195